Hims & Hers Health, Inc. (HIMS) · Oct 7, 2026 · Exec change
CAO appointment — Planned October 9 departure replaced by October 9 appointment; $3.0M RSU grant
Hims & Hers appointed Jonathan Franklin as chief accounting officer, replacing a departing executive in a planned transition with a sizable equity package.
Hims & Hers is scaling from a U.S. telehealth brand into a global consumer-health platform, with international acquisitions and a major shift toward weight-loss care and GLP-1 access. Against that backdrop, this is an accounting-leadership transition rather than a change to the operating strategy.
The succession was expected, not a surprise. Irene Becklund’s October 9 departure had already been disclosed, including her planned advisory role through July 2027; the new information is that Jonathan Franklin will take over the principal-accounting-officer role on that same date. 〔0〕 The appointment removes interim-accounting uncertainty, but it does not materially alter the company’s business story.
The hire brings public-company accounting experience, but no demonstrated strategic reset. Franklin spent more than four years in senior accounting roles at Rivian before joining Hims & Hers and previously worked at PwC. That background should support reporting as Hims & Hers integrates acquisitions and expands internationally, but the filing provides no evidence of a change in accounting policy, controls, or financial outlook.
The compensation is meaningful, but not a fresh operating commitment. Franklin receives a $425,000 salary, a $150,000 signing bonus, and $3.0 million of restricted stock units, with a 50% target annual bonus. The package creates dilution and expense over time, but the filing does not establish that it is out of line for a senior accounting hire or that it changes capital-allocation priorities.
Bottom line: This completes a previously announced accounting succession with continuity and no disclosed accounting dispute. It matters for execution and reporting infrastructure, but only modestly changes the broader Hims & Hers growth story.
Becklund advisory support through July 10, 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!